Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Cash on Hand 2016–2025
Urogen Pharma Ltd. annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Urogen Pharma Ltd. cash on hand for the quarter ending December 31, 2025 were 110.7M, a 35.61% decrease year-over-year.
- Urogen Pharma Ltd. cash on hand for 2025 were 110.7M, a 35.61% decrease from 2024.
- Urogen Pharma Ltd. cash on hand for 2024 were 172.0M, a 81.04% increase from 2023.
- Urogen Pharma Ltd. cash on hand for 2023 were 95.0M, a 71.46% increase from 2022.
- Urogen Pharma Ltd. cash on hand for 2022 were 55.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Urogen Pharma Ltd. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $111 |
| 2024 | $172 |
| 2023 | $95 |
| 2022 | $55 |
| 2021 | $44 |
| 2020 | $53 |
| 2019 | $50 |
| 2018 | $101 |
| 2017 | $37 |
| Urogen Pharma Ltd. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $111 |
| 2024-12-31 | $172 |
| 2023-12-31 | $95 |
| 2022-12-31 | $55 |
| 2021-12-31 | $44 |
| 2020-12-31 | $53 |
| 2019-12-31 | $50 |
| 2018-12-31 | $101 |
| 2017-12-31 | $37 |
Urogen Pharma Ltd. Cash on Hand — FAQ
Urogen Pharma Ltd. (URGN) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see URGN's cash on hand history?
The chart and table above show Urogen Pharma Ltd.'s cash on hand by year and by quarter, including the growth rate.